The Cost of Reaching National Cholesterol Education Program (NCEP) Goals in Hypercholesterolaemic Patients
- 1 January 1998
- journal article
- clinical trial
- Published by Springer Nature in PharmacoEconomics
- Vol. 14 (1), 59-70
- https://doi.org/10.2165/00019053-199814010-00006
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Atorvastatin--a new lipid-lowering drug.1997
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Cost-Effectiveness of Pravastatin in Secondary Prevention of Coronary Artery DiseaseThe American Journal of Cardiology, 1996
- Cost-effectiveness of cholesterol lowering: Results from the Scandinavian Simvastatin Survival Study (4S)European Heart Journal, 1996
- Prevention of Coronary Heart Disease with Pravastatin in Men with HypercholesterolemiaNew England Journal of Medicine, 1995
- Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)1993
- Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.1991
- An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence.Circulation, 1990
- Cholesterol and mortality. 30 years of follow-up from the Framingham studyJAMA, 1987
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative UltracentrifugeClinical Chemistry, 1972